Related Experiment Videos
MDM2 gene amplification in human breast cancer
B Quesnel1, C Preudhomme, J Fournier
1Service des Maladies du Sang, Institut de Recherches sur le Cancer, France.
European Journal of Cancer (Oxford, England : 1990)
|January 1, 1994
Summary
MDM2 gene amplification is rare in breast cancer, occurring in only one of 60 cases, often with high estrogen receptor (ER) levels. Further research is needed to clarify the MDM2 gene and ER status relationship.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The MDM2 gene product interacts with and regulates p53 functions.
- MDM2 gene amplification is observed in approximately one-third of human sarcomas.
- Differential MDM2 gene expression relative to estrogen receptor (ER) status has been noted in breast cancer cell lines.
Purpose of the Study:
- To investigate the frequency of MDM2 gene amplification in human breast cancers.
- To explore the potential association between MDM2 gene amplification and ER status in breast cancer patients.
Main Methods:
- Analysis of 60 breast cancer tissue samples.
- Utilized Southern blot technique to detect MDM2 gene amplification.
Main Results:
- MDM2 gene amplification was detected in only one out of 60 breast cancer cases analyzed.
- The single case with MDM2 gene amplification also exhibited high levels of estrogen receptor (ER).
Conclusions:
- MDM2 gene amplification appears to be an infrequent event in the development of breast cancer.
- Additional studies are required to fully elucidate the relationship between MDM2 amplification and ER status in breast cancer.